HPGC Renmintongtai Pharmaceutical Corp (600829) — Cash Flow Reinvestment Rate
HPGC Renmintongtai Pharmaceutical Corp (600829) has a Cash Flow Reinvestment Rate of 0.02x as of June 2025, reinvesting CN¥3.09 Million (capex CN¥1.55 Million plus investments CN¥-1.55 Million) from operating cash flow of CN¥176.16 Million. Explore HPGC Renmintongtai Pharmaceutical Corp (600829) capital reinvestment to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
HPGC Renmintongtai Pharmaceutical Corp Cash Flow Reinvestment Rate (1998–2025)
Historical reinvestment intensity for HPGC Renmintongtai Pharmaceutical Corp across 22 annual periods. Also explore HPGC Renmintongtai Pharmaceutical Corp asset portfolio for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for HPGC Renmintongtai Pharmaceutical Corp (1998–2025)
Year-by-year capital reinvestment analysis for HPGC Renmintongtai Pharmaceutical Corp. For live market cap and broader valuation context, see how much is HPGC Renmintongtai Pharmaceutical Corp worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.06x | CN¥17.16 Million | CN¥299.98 Million | CN¥17.16 Million | ▼ -58.6% |
| 2024 | 0.14x | CN¥15.94 Million | CN¥115.44 Million | CN¥8.04 Million | ▼ -77.4% |
| 2023 | 0.61x | CN¥203.34 Million | CN¥332.99 Million | CN¥23.48 Million | ▲ +1427.4% |
| 2022 | 0.04x | CN¥12.29 Million | CN¥307.33 Million | CN¥6.42 Million | ▲ +36.3% |
| 2018 | 0.03x | CN¥10.75 Million | CN¥366.45 Million | CN¥5.73 Million | ▼ -71.1% |
| 2017 | 0.10x | CN¥14.10 Million | CN¥139.07 Million | CN¥7.10 Million | ▼ -89.6% |
| 2016 | 0.97x | CN¥44.74 Million | CN¥46.01 Million | CN¥22.81 Million | ▲ +812.9% |
| 2015 | 0.11x | CN¥35.58 Million | CN¥333.99 Million | CN¥35.58 Million | ▲ +145.1% |
| 2014 | 0.04x | CN¥17.06 Million | CN¥392.58 Million | CN¥17.06 Million | ▼ -68.5% |
| 2012 | 0.14x | CN¥30.56 Million | CN¥221.57 Million | CN¥30.56 Million | ▼ -59.1% |
| 2010 | 0.34x | CN¥54.90 Million | CN¥162.99 Million | CN¥54.90 Million | ▲ +61.6% |
| 2009 | 0.21x | CN¥93.36 Million | CN¥447.82 Million | CN¥93.36 Million | ▼ -6.8% |
| 2007 | 0.22x | CN¥42.76 Million | CN¥191.10 Million | CN¥42.76 Million | ▼ -40.4% |
| 2006 | 0.38x | CN¥71.74 Million | CN¥191.13 Million | CN¥71.74 Million | ▲ +236.1% |
| 2005 | 0.11x | CN¥34.96 Million | CN¥313.04 Million | CN¥34.96 Million | ▼ -90.7% |
| 2004 | 1.20x | CN¥72.69 Million | CN¥60.69 Million | CN¥72.69 Million | ▼ -56.1% |
| 2003 | 2.73x | CN¥195.45 Million | CN¥71.65 Million | CN¥195.45 Million | ▲ +528.6% |
| 2002 | 0.43x | CN¥55.32 Million | CN¥127.49 Million | CN¥55.32 Million | ▼ -81.8% |
| 2001 | 2.39x | CN¥35.35 Million | CN¥14.79 Million | CN¥35.35 Million | ▲ +142.0% |
| 2000 | 0.99x | CN¥61.09 Million | CN¥61.85 Million | CN¥61.09 Million | ▲ +32.3% |
| 1999 | 0.75x | CN¥43.45 Million | CN¥58.21 Million | CN¥43.45 Million | ▲ +48.9% |
| 1998 | 0.50x | CN¥20.55 Million | CN¥41.00 Million | CN¥20.55 Million | — |